Source: Netherlands Institute for Neuroscience - KNAW Jan 20, 2019
Researchers from the Netherlands Institute for Neuroscience (NIN) and the Leiden University Medical Center (LUMC) have shown that treatment using gene therapy leads to a faster recovery after nerve damage. By combining a surgical repair procedure with gene therapy, the survival of nerve cells and regeneration of nerve fibers over a long distance was stimulated for the first time. The discovery, pu...
Thailand Medical News Jan 20, 2019
Positive news for Thailand’s healthcare sector was highly welcome when Bloomberg released their Global Health Care Efficiency Index in the last quarter of 2018.
Thailand Medical News reviews these extremely positive results and suggest why momentum must be maintained as well as 2 challenges that must be addressed in order for this momentum to be carried forward on a continuous basis...
Source: University of Michigan Jan 20, 2019
A new study finds acupressure could be a low-cost, at-home solution to a suite of persistent side effects that linger after breast cancer treatment ends.
Researchers from the University of Michigan Rogel Cancer Center reported in 2016 that acupressure helped reduce fatigue in breast cancer survivors.
In the new study, they looked at the impact of acupressure on symptoms that frequently accompa...
Source: Eli Lilly and Company Jan 20, 2019
REACH-2 is the first positive Phase 3 hepatocellular carcinoma trial in a biomarker-selected population known for poor prognosis
Pooled data analyses of AFP-High patients in the REACH-2 and REACH trials showed an improvement of 3.1 months in median overall survival
Eli Lilly and Company (NYSE: LLY) announced that results from the global Phase 3 REACH-2 study of CYRAMZA® (ram...
Source: Hong Kong Baptist University Jan 19, 2019
Epstein-Barr virus infects more than 95 percent of people, usually without symptoms. But sometimes its persistence in cells can lead to tumor formation. Now, researchers from Hong Kong and the UK have developed a fluorescing, molecular-sized probe, called L2P4, which can inhibit Epstein-Barr-related tumor growth while allowing researchers to see the targeted tumor cells.
Epstein-Barr vi...
